*original volume: serum (100-200ul), BAL fluid (1ml)
<Virus-specific antibody ELISA>.
1. Coating with PFA-inactivated (PR8 virus incubated in 0.1% PFA in PBS for 1 wk at 4'c) PR8 virus (106 pfu equivalent per 100ul
2. Sample dilution: indicated in the figure (need to be serially diluted)
3. Capture with HRP-conjugated anti-mouse lgG2b, lgG2c, IgA....
Anti-mouse lgM-HRP (1020-05)(SouthernBiotec) 1/1000
Anti-mouse lgG1-HRP(1070-05): 1/1000
Anti-mouse lgG2c-HRP(1079-05): 1/1000
Anti-mouse lgG3-HRP(1100-05):1/1000
Anti-mouse lA-HRP(1040-05): 1/1000
Anti-mouse lgG2b-HRP(1090-05):1/1000
<Secretory IgA ELISA>
1. Coating with 2ug/ml goat anti-mouse plgR purified Ab (R&D systems, #AF2800)
2. Sample (BAL fluid) dilution: 1:50~1:200
3. Capture with HRP-conjugated anti-mouse lgA (SothernBiotech #1040-05, 1:1000)
<pIgR(SC) ELISA>
1. Coating with BAL fluid (1:50/ for standard curve. coatina with recombinant plR protein (R&D systems, #2800-PG-050)
2. Sample: 2ug/ml goat anti-mouse plgR purified Ab (R&D systems, #AF2800)
3. Capture with 1:100 HRP Donkey anti-goat lgG (H+L) (Jackson lmmunoresearch, #705-035-147)
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.